These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 26654228)
1. Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica. Fragoso YD Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):16-20. PubMed ID: 26654228 [TBL] [Abstract][Full Text] [Related]
3. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340 [TBL] [Abstract][Full Text] [Related]
4. Variants of autophagy-related gene 5 are associated with neuromyelitis optica in the Southern Han Chinese population. Cai PP; Wang HX; Zhuang JC; Liu QB; Zhao GX; Li ZX; Wu ZY Autoimmunity; 2014 Dec; 47(8):563-6. PubMed ID: 24953774 [TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. Kira J J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794 [TBL] [Abstract][Full Text] [Related]
11. The spectrum of neuromyelitis optica. Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564 [TBL] [Abstract][Full Text] [Related]
12. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113 [TBL] [Abstract][Full Text] [Related]
13. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Dale RC; Brilot F; Banwell B Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783 [TBL] [Abstract][Full Text] [Related]
14. [Novel therapeutic target in neuromyelitis optica and multiple sclerosis: high mobility group box 1 (HMGB1)]. Mori M Rinsho Shinkeigaku; 2014; 54(12):975-7. PubMed ID: 25672684 [TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica: concept, immunology and treatment. Uzawa A; Mori M; Kuwabara S J Clin Neurosci; 2014 Jan; 21(1):12-21. PubMed ID: 23916471 [TBL] [Abstract][Full Text] [Related]
17. NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases. Vaknin-Dembinsky A; Karussis D; Avichzer J; Abramsky O J Autoimmun; 2014 Nov; 54():93-9. PubMed ID: 25129503 [TBL] [Abstract][Full Text] [Related]
18. Variants of CYP27B1 are associated with both multiple sclerosis and neuromyelitis optica patients in Han Chinese population. Zhuang JC; Huang ZY; Zhao GX; Yu H; Li ZX; Wu ZY Gene; 2015 Feb; 557(2):236-9. PubMed ID: 25542806 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis. Simon KC; Schmidt H; Loud S; Ascherio A Mult Scler; 2015 May; 21(6):703-9. PubMed ID: 25305254 [TBL] [Abstract][Full Text] [Related]
20. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review]. Yoshida M Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]